B2M and plasma cell myeloma: For the MMIn data, elevated levels of β2M and calcium with lower levels of eGFR and hemoglobin contributed to high risk, whereas in the MMRF data, elevated levels of β2M and lower levels of hemoglobin, eGFR, and albumin contributed to high risk in myeloma patients.